Uttam Yashwant Patil
Fortuna: 76 774 $ al 30/09/2026
Fortuna: 76 774 $ al 30/09/2026
Dr. Uttam Yashwant Patil is a Co-Chief Executive Officer at AiBtl BioPharma, Inc., a Chief Executive & Financial Officer at ABVC BioPharma, Inc., a Chief Operating & Scientific Officer at Biokey, Inc. and a Manager-Research & Development at Rgene Corp.
He received his undergraduate degree from the University of Pune, a graduate degree from the University of Pune and a doctorate degree from National Tsing-Hua University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ABVC BIOPHARMA, INC. 0,27 % | 27/02/2026 | 72.428 ( 0,27 % ) | 76 774 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ABVC BIOPHARMA, INC. | Director Ejecutivo | 21/06/2023 |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Director de Operaciones | 01/05/2023 |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Director Técnico/Científico/I+D | 01/05/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
National Tsing-Hua University
National Tsing-Hua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pune
University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABVC BioPharma, Inc.
ABVC BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops drugs and medical devices in the fields of oncology, ophthalmology and central nervous system | Health Technology |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Health Technology |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.